Western Blot: KRT23 Antibody - Samples: Lane 1, Marker: 250, 130, 95, 72, 55, 36, 28, 17, 11 Lane 2, RT-4 Lane 3, U-251MG sp Lane 4, Human Plasma Lane 5, Liver Lane 6, Tonsil, Target weight: 48, 4 (splice variants) Validation score: 2 Validation description: Supportive - Band of predicted size in kDa (+/-20%) with additional bands present.
ELISA: KRT23 Antibody
Immunohistochemistry: KRT23 Antibody - Normal glandular cells showed moderate cytoplasmic immunoreactivity while most other cell types were weakly stained or negative. Exocrine pancreas, placental trophoblasts, adrenal cortical cells and Leydig cells in testis revealed strong positivity. A majority of malignant cells displayed moderate cytoplasmic immunoreactivity. Thyroid cancers and few cases of colorectal cancers revealed strong positivity. Most skin cancers, malignant lymphomas and gliomas were negative. Image and statement courtesy of the Human Protein Atlas (HPA). View all of the IHC expression profiles performed by the Human Protein Atlas.